Clinical Trial Update: ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing high-dose chemotherapy for aggressive non-Hodgkin lymphoma and related lymphomas; study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Non-hodgkin Lymphoma
• Lymphoma B-cell
• Lymphoma T-cell

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Aggressive Non-hodgkin Lymphoma (aNHL), Lymphoma, B-Cell | Phase 2 | Status: COMPLETED